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Abstract 
Nowadays, pharmaceutical industry demands competitive and eco-
friendly processes for active pharmaceutical ingredients (APIs) 
manufacturing. In this context, enzyme and whole-cell mediated 
processes offer an efficient, sustainable and cost-effective alternative 
to the traditional multi-step and environmentally-harmful chemical 
processes. Particularly, 2′-deoxyribosyltransferases (NDTs) have 
emerged as a novel synthetic alternative, not only to chemical but 
also to other enzyme-mediated synthetic processes. This review 
describes recent findings in the development and scaling up of NDTs 
as industrial biocatalysts, including the most relevant and recent 
examples of single enzymatic steps, multienzyme cascades, chemo-
enzymatic approaches, and engineered biocatalysts. Finally, to 
reflect the inventive and innovative steps of NDT-mediated 
bioprocesses, a detailed analysis of recently granted patents, with 
specific focus on industrial synthesis of nucleoside-based APIs, is 
hereunder presented. 
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